ONDANSETRON HCL SOLUTION

Formula & Concentration

ONDANSETRON- ondansetron injection, solution

Manufacturer

Pfizer Inc.

Indications

Ondansetron Injection is a 5-HT3 receptor antagonist indicated for the prevention of:

• nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy. (1.1)

• postoperative nausea and/or vomiting. (1.2)

Product Options

Package Size

NDC #

Presentation

4 mg

72266-0123-25

Vial

40 mg

00409-4759-01

Vial

Shelf Life and Storage

Store at 20°C to 25°C (68°F to 77°F). [See USP Controlled Room Temperature.] Product may also be stored in a refrigerator, 2°C to 8°C (36°F to 46°F). Retain in carton until time of use. Protect from light.